During the past decade, Fundación Jiménez Díaz-Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundación Jiménez Díaz-Oncology" are "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Endometrial Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "Fundación Jiménez Díaz-Oncology" in a lesser frequency.

Most popular intervention types in "Fundación Jiménez Díaz-Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Alpelisib" (1 trials), "Aromatase Inhibitor (AI)" (1 trials), "Everolimus" (1 trials) and "LY3300054" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundación Jiménez Díaz-Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fundación Jiménez Díaz-Oncology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fundación Jiménez Díaz-Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundación Jiménez Díaz-Oncology, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".